Table 5.
Relative risks and attributable risk of tuberculosis infection conversion (TBIC) in the cohort study following vitamin D status by Poisson regression
| Stratum | TBIC cases | Non-cases | Total | RR (95% CI) | AR (%)* (95% CI) |
|---|---|---|---|---|---|
| High exposure and TB sputum AFB-positive index case = 1 | |||||
| Vitamin D <20 ng/ml | 1 | 1 | 2 | 2·75 | |
| Vitamin D ⩾20 ng/ml | 2 | 9 | 11 | (0·25–30·32) | |
| High exposure and TB sputum AFB-positive index case = 0 |
|||||
| Vitamin D <20 ng/ml | 10 | 49 | 59 | 4·27 | |
| Vitamin D ⩾20 ng/ml | 5 | 121 | 126 | (1·46–12·5) | |
| Adjusted results by Poisson regression | 3·96 (1·51–10·37) | 45·7% (20·6–55·2) |
AFB, Acid-fast bacilli; RR, relative risk; AR, attributable risk; CI, Confidence interval; TB, tuberculosis.
Formula attributable risk: pd (RR – 1)/RR (where pd÷proportion of cases with vitamin D <20 ng/ml): 11/18 = 0·61.